Ly6a-KO Mouse

Ly6a, also known as Stem Cell Antigen-1 (Sca-1), is a glycosylphosphatidylinositol (GPI)-anchored protein. It has been implicated in multiple biological processes. In hematopoiesis, its function was initially thought to be limited, but recent studies show broader roles. It may be involved in cell-fate determination, and its expression can influence the response to inductive signals in early limb bud cells [4]. It also plays a part in the regulation of immune responses and is associated with pathways related to viral resistance, inflammation, and T-cell-mediated immunity [1,2,5]. Genetic models, especially mouse models, are crucial for studying Ly6a.

In a Sca-1 knockout (KO) mouse model, loss of Sca-1 alone had little effect on bladder development or function but reduced the total number of mesenchymal stem cells by 30%. After partial bladder outlet obstruction (PO), Sca-1-null KO male mice had larger bladders with more collagen and less muscle, indicating that Sca-1 protects the bladder from fibrotic remodeling, likely by influencing the proliferation of cells responding to injury [3]. Additionally, high-density conditions of sSca+ (Sca-1-positive) subpopulation in limb bud cells showed promotion of tenogenic differentiation and delay of chondrogenesis, suggesting Sca-1 expression's role in cell-fate determination during development [4].

In conclusion, Ly6a is involved in diverse biological functions such as immune response regulation, cell-fate determination during development, and protection against bladder fibrosis. Mouse KO models have been instrumental in revealing its role in these processes, especially in the context of bladder fibrosis. These findings contribute to our understanding of related biological processes and potentially, to the development of therapies for diseases where Ly6a-related mechanisms are disrupted.

References:

1. Maliah, Avishai, Santana-Magal, Nadine, Parikh, Shivang, Carmi, Yaron, Levy, Carmit. 2024. Crosslinking of Ly6a metabolically reprograms CD8 T cells for cancer immunotherapy. In Nature communications, 15, 8354. doi:10.1038/s41467-024-52079-x. https://pubmed.ncbi.nlm.nih.gov/39333093/

2. Parsa, Roham, London, Mariya, Rezende de Castro, Tiago Bruno, Smith, Jason G, Mucida, Daniel. 2022. Newly recruited intraepithelial Ly6A+CCR9+CD4+ T cells protect against enteric viral infection. In Immunity, 55, 1234-1249.e6. doi:10.1016/j.immuni.2022.05.001. https://pubmed.ncbi.nlm.nih.gov/35617965/

3. Tassone, Nicholas M, Li, Belinda, Patel, Mehul S, Dettman, Robert W, Gong, Edward M. 2019. Stem cell antigen/Ly6a protects against bladder fibrosis in mice. In American journal of physiology. Renal physiology, 317, F1503-F1512. doi:10.1152/ajprenal.00160.2019. https://pubmed.ncbi.nlm.nih.gov/31532245/

4. Marín-Llera, Jessica Cristina, Lorda-Diez, Carlos Ignacio, Hurle, Juan Mario, Chimal-Monroy, Jesús. 2021. SCA-1/Ly6A Mesodermal Skeletal Progenitor Subpopulations Reveal Differential Commitment of Early Limb Bud Cells. In Frontiers in cell and developmental biology, 9, 656999. doi:10.3389/fcell.2021.656999. https://pubmed.ncbi.nlm.nih.gov/34336823/

5. Shmerling, Moriya, Chalik, Michael, Smorodinsky, Nechama I, Witz, Isaac P, Wreschner, Daniel H. 2022. LY6S, a New IFN-Inducible Human Member of the Ly6a Subfamily Expressed by Spleen Cells and Associated with Inflammation and Viral Resistance. In ImmunoHorizons, 6, 253-272. doi:10.4049/immunohorizons.2200018. https://pubmed.ncbi.nlm.nih.gov/35440514/